IRIS

Sammartano, V., Santoni, A., Frediani, B., Sicuranza, A., Emanuele, C., Franchi, F., et al. (2020). Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant). LEUKEMIA & LYMPHOMA, 61(14), 3523-3525 [10.1080/10428194.2020.1817440].

Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant)

Sammartano V.;Santoni A.;Frediani B.;Sicuranza A.;Franchi F.;Bocchia M.
2020-01-01
2020
LEUKEMIA & LYMPHOMA
Sammartano, V., Santoni, A., Frediani, B., Sicuranza, A., Emanuele, C., Franchi, F., et al. (2020). Efficacy and safety of ruxolitinib for Covid-19 related acute respiratory distress syndrome in a patient with blastic plasmacytoid dendritic cell neoplasm (leukemic variant). LEUKEMIA & LYMPHOMA, 61(14), 3523-3525 [10.1080/10428194.2020.1817440].
1.1 Articolo in rivista
File in questo prodotto:
Non ci sono file associati a questo prodotto.

I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11365/1116240